MedPath

To test efficacy of Indrayavadi yoga in heavy menstrual bleeding.

Phase 2
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary system
Registration Number
CTRI/2021/05/033326
Lead Sponsor
Priyanka Dilipkumar Sahu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosed patients of DUB having age group 20 to 45 Years .

2.Selection irrespective of marital status, parity, socio-economic status.

3.Patient having sign and symptoms of Asrugdara.

4.Excessive bleeding more than two consecutive cycles.

5.Those having Intermenstrual bleeding

6.Excessive bleeding per vagina during menstruation either in amount or in duration or both.

7.Hb > 8%gm/dl.

Exclusion Criteria

1.Patients having blood dyscrasias

2.Major systemic disease likely to influence menstrual cycle like HTN , DM , TB , HIV , Thyroid, Kidney

3.Known Patients of malignancy, cervical erosion, polyp, adenomyosis, pelvic endometriosis, tubo-ovarian mass , PCOD.

4.Known case of structural anomalies of genital organs.

5.Patients using IUCD.

6.Patients undergoing treatment for any other serious illness.

7.Those having postmenopausal bleeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of Indrayavadi yoga in Asrugdara and to control amount and duration of bleeding <br/ ><br>Timepoint: 3months
Secondary Outcome Measures
NameTimeMethod
Effect of shunthi lodhra yoga in Asrugdara in control groupTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath